Assessing Composite Outcomes in Clinical Trials - Students 4 Best Evidence
Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis
Clinical Trials With Multiple Endpoints: Pitfalls And Management | Premier Consulting
The Primary Outcome Fails — What Next? | NEJM
A study design with conditional, serially assessed coв•'primary endpoints: An application to a singleв•'arm, pilot non
Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
The Regulatory Strategist Toolbox: Clinical Endpoint Analysis Tools | RAPS
Clinical Trial Endpoints for Oncology Studies
Co-primary Endpoint Data: Moderate to Severe Plaque Psoriasis | TREMFYA® (guselkumab) HCP
Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials | tctmd.com
Biohaven Announces Successful Achievement of Both Co-Primary Regulatory Endpoints in Two Pivotal Phase 3 Trials of Rimegepant an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine | Biohaven Pharmaceuticals
Composite End Points in Clinical Research | Circulation
5.3 Leveraging multiple endpoints in small clinical trials (Robin Ristl)
Multiplicity – What is it, and why is it important? - Quantics Biostatistics
PDF) A multiple testing framework for diagnostic accuracy studies with co-primary endpoints
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review: Journal of Biopharmaceutical Statistics: Vol 28, No 1
PulmCrit Wee- Secondary endpoints: Can we separate the wheat from the chaff?
The Regulatory Strategist Toolbox: Clinical Endpoint Analysis Tools | RAPS
Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials - Yu - 2022 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Sequential sample size re-estimation in clinical trials with multiple co-primary endpoints - WRAP: Warwick Research Archive Portal
Can Huntington's disease clinical trial design tweaks lead to success?
